Neuralstem Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Neuralstem Inc
TickerPALI
CIK #0001357459
CUSIP696389105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address9700 Great Seneca Highway, Rockville, MD 20850
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Palisade Bio Inc 2024-05-10 4.0 M Exemption: 506(b) · Duration: One year or less · Commission: $309,999 · Revenue: Decline to Disclose
Seneca Biopharma Inc 2020-01-28 7.6 M Exemption: 506(b) · Duration: One year or less · Commission: $604,444 · Revenue: Decline to Disclose
Neuralstem Inc 2017-05-31 0.0 M Exemption: 506(b) · Minimum: $12,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001357459] 10-K
[0001357459] 10-Q
[0001357459] 3
[0001357459] 4
[0001357459] 5
[0001357459] 8-K
[0001357459] D
[0001357459] SC 13D
[0001357459] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Soleus Capital Master Fund LP Palisade Bio Inc [2026-05-27] 0.0
Ameriprise Financial Inc Palisade Bio Inc [2026-05-15] 0.0
Octagon Capital Advisors LP Palisade Bio Inc [2026-02-10] 0.0
Franklin Resources Inc Palisade Bio Inc [2026-01-29] 0.0
Janus Henderson Group PLC Palisade Bio Inc [2025-12-08] 0.0
Perceptive Advisors LLC Palisade Bio Inc [2025-10-09] 0.0
RA Capital Management LP Palisade Bio Inc [2025-10-09] 0.0
Deep Track Capital LP Palisade Bio Inc [2025-10-08] 0.0
Commodore Capital LP Palisade Bio Inc [2025-10-08] 0.0
Squadron Capital Management LLC Palisade Bio Inc [2025-10-08] 0.0
Point72 Asset Management LP Palisade Bio Inc [2025-10-07] 0.0
Armistice Capital LLC Palisade Bio Inc [2024-11-14] 0.99
Lind Global Fund II LP Palisade Bio Inc [2023-09-15] 7.9
L1 Capital Global Opportunities Master Fund Ltd Palisade Bio Inc [2023-09-15] 6.4
Armistice Capital LLC Palisade Bio Inc [2023-02-14] 0.99
Intracoastal Capital LLC Palisade Bio Inc [2022-08-22] 0.99
Lind Global Fund II LP Palisade Bio Inc [2022-08-18] 6.2
Altium Capital Management LP Palisade Bio Inc [2022-02-14] 9.99
YUMA Regional Medical Center Palisade Bio Inc [2021-08-30] 19.0
Altium Capital Management LP Palisade Bio Inc [2021-05-11] 9.82
Armistice Capital LLC Seneca Biopharma Inc [2020-05-29] 4.99
Renaissance Technologies LLC Seneca Biopharma Inc [2020-02-12] 6.7
Intracoastal Capital LLC Neuralstem Inc [2019-08-09] 0.99
Armistice Capital LLC Neuralstem Inc [2018-11-05] 5.7
Sabby Management LLC Neuralstem Inc [2018-10-26] 8.26
Hudson Bay Capital Management LP Neuralstem Inc [2018-02-02] 5.83
CVI Investments Inc Neuralstem Inc [2017-08-07] 8.3
Tianjin Pharmaceuticals Group Holdings Co Ltd Neuralstem Inc [2017-02-27] 19.99
Putnam Investments LLC Neuralstem Inc [2015-02-17] 6.5
JOHE Karl Neuralstem Inc [2014-03-06] 14.1
GARR Richard Neuralstem Inc [2014-03-06] 7.5
[2012-08-22] None
[2012-02-16] None
Form 3/4/5 Filer 2011 - 2026
Baltera Robert Jr
Palisade Bio Inc
Jones Mitchell Lawrence
Finley John David
Zwick Jordan Michael
Chuang Emil
Wei Binxian
Williams Donald Allen
Fischbein Margery B
Diaz Stephanie
Trenschel Robert J
Neal James R
Csimma Cristina
Gray Mary Ann
McRae Robert Curtis
Hallam Thomas
Dawson Michael John
Yuma Regional Medical Center
Mazzo David J
Carter Kenneth C
Smith Sandford D
Oldaker William Clyde
Ogilvie Scott Varde
Westreich Stanley
Daly Richard J
Lloyd Jones Jonathan Brian
GARR Richard
JOHE Karl
Sohn Catherine A
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Finley John David
Common Stock
2026-02-12 Sell 3,896 $1.75 6,818
Jones Mitchell Lawrence
Common Stock
2026-02-12 Sell 1,989 $1.75 3,481
Finley John David
Common Stock
2026-02-11 Option exercise 13,333
Jones Mitchell Lawrence
Common Stock
2026-02-11 Option exercise 8,000
Finley John David
Restricted Stock Units · derivative
2026-02-11 Option exercise 13,333 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2026-02-11 Option exercise 8,000 $0.00
Finley John David
Restricted Stock Units · derivative
2026-02-09 Grant 2,011,000 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2026-02-09 Grant 787,000 $0.00
Williams Donald Allen
Common Stock
2026-01-16 Buy 5,000 $1.67 8,350
Williams Donald Allen
Common Stock
2026-01-09 Buy 5,000 $1.88 9,400
Williams Donald Allen
Restricted Stock Units · derivative
2025-10-06 Grant 1,538,700 $0.00
Jones Mitchell Lawrence
Restricted Stock Units · derivative
2025-10-06 Grant 7,665,800 $0.00
Finley John David
Restricted Stock Units · derivative
2025-10-06 Grant 9,179,400 $0.00
Wei Binxian
Restricted Stock Units · derivative
2025-10-06 Grant 510,700 $0.00
Chuang Emil
Restricted Stock Units · derivative
2025-10-06 Grant 510,700 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 60,600 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 60,600 $0.00
Restricted Stock Units · derivative
2025-10-06 Grant 182,000 $0.00
Phantom Units · derivative
2025-09-04 Grant 18,800 $0.00
Phantom Units · derivative
2025-09-04 Grant 289,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 96 149,265,837
2025-12-31 86 135,864,648
2025-09-30 12 119,592
2025-06-30 12 84,610
2025-03-31 14 296,358
2024-12-31 11 234,982
2024-09-30 10 106,057
2024-06-30 9 65,837
2024-03-31 17 970,269
2023-12-31 17 306,071
2023-09-30 14 149,932
2023-06-30 12 134,550
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 450,543 450,543
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 29,228
NorthCrest Asset Manangement LLC [2026-06-30] SOLE 0 12,203
FNY Investment Advisers LLC [2026-06-30] SOLE 8,500 10
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com